High Expression of MDR1 is Correlated with Poor Prognosis for Common Malignancies
High Expression of MDR1 is Correlated with Poor Prognosis for Common Malignancies
Bo Gao1,2, Fengmei Yang3, Wei Chen2, Xiaojia Song4, Xiaobo Liu5 and Dongmin Li1*
Fig. 1.
The relative expression levels of MDR1 in all tissues.
Fig. 2.
Recurrence time and survival time in different groups. PEOC: primary epithelial ovarian cancer; NSCLC: non-small cell lung cancer; MDR1: multidrug resistance 1; MDR1+: MDR1 positive group; MDR1-: MDR1 negative group.
Fig. 3.
The ROC analysis of MDR1 expression and tumor markers in the prognosis of common malignant tumor.
Fig. 4.
Survival curves of MDR1 mRNA-positive and negative patients. A: non-small cell lung cancer; B: colorectal cancer; C: primary epithelial ovarian cancer; D: gastric cancer; E:breast cancer.
August 2020
Vol. 52, Iss. 4, Pages 1225-1630
